Danville, IN, United States of America

Ronald E Zimmerman


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Danville, IN (US) (1981 - 1985)
  • Indianapolis, IN (US) (1993)

Company Filing History:


Years Active: 1981-1993

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Ronald E. Zimmerman

Introduction

Ronald E. Zimmerman is a notable inventor based in Danville, IN (US). He has made significant contributions to the field of medical treatments, particularly in thromboembolic disorders and contraceptive methods. With a total of 7 patents to his name, his work has had a considerable impact on healthcare.

Latest Patents

Zimmerman's latest patents include groundbreaking inventions such as compounds and methods for the treatment of thromboembolic disorders. This invention provides adducts of human t-PA derivatives, which comprise a t-PA derivative that lacks the Finger, Growth Factor, and Kringle 1 domains, bound to an amphipathic molecule. Additionally, he has developed contraceptive methods involving long-chain alkyl and alkenyl sulfonates, sulfates, and sulfoalkyl alkanoate salts, which are administered intravaginally for contraception.

Career Highlights

Throughout his career, Zimmerman has been associated with Eli Lilly and Company, where he has been able to leverage his expertise in pharmaceutical innovations. His work has not only advanced medical treatments but has also contributed to the overall mission of improving patient care.

Collaborations

Zimmerman has collaborated with esteemed colleagues such as Philip J. Burck and Arvind L. Thakkar. These partnerships have fostered an environment of innovation and have led to the development of impactful medical solutions.

Conclusion

In summary, Ronald E. Zimmerman is a distinguished inventor whose work in medical treatments has led to significant advancements in healthcare. His contributions continue to influence the field and improve the lives of many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…